Off-label uses of the Amplatzer Piccolo Occluder in children with congenital and acquired heart diseases.
Future Cardiol
; 20(9): 459-470, 2024.
Article
em En
| MEDLINE
| ID: mdl-39234889
ABSTRACT
Aim:
The Amplatzer Piccolo Occluder (APO) is approved for patent ductus arteriosus (PDA) occlusion in infants weighing >700 g but could offer versatility to treat other lesions.Methods:
Retrospective review of children in whom APO was utilized for defects other than PDA between January 2022 and June 2023.Results:
The APO was used in nine patients; three for ventricular septal defects, four with coronary fistulas, one for a ventricular pseudoaneurysm and one where APO deployed within a fenestration of a previously placed Amplatzer Septal Occluder. All nine patients had successful occlusions without complications.Conclusion:
The APO is a versatile device that can be used to treat various small diameter lesions in children besides the PDA for which it is currently approved for.
[Box see text].
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Dispositivo para Oclusão Septal
Limite:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Future Cardiol
/
Future cardiol
/
Future cardiology
Assunto da revista:
CARDIOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos
País de publicação:
Reino Unido